Results 151 to 160 of about 9,302 (232)

Drug-specific safety signal prioritization of antibody-drug conjugates in breast cancer: integrating FAERS pharmacovigilance, machine learning, and clinical contextualization. [PDF]

Front Pharmacol
Tang Y, Liu S, Zhu Y, Fan L, Han X, Ma W, Zhang H, Sui Z, Pang H, Zhao W.   +9 more
europepmc   +1 more source

A manufacturer-aware cross-system benchmark for pediatric pharmacovigilance signal concordance. [PDF]

Front Pharmacol
Shi J, Xia J, Li H, Zhang S, Shi B.
europepmc   +1 more source

Age-stratified safety signal mining of ADHD medications in pediatric populations using the FAERS database (2014-2024): a pharmacovigilance study using multi-method disproportionality analysis. [PDF]

Front Pediatr
Qin G, Chen L.
europepmc   +1 more source

Endothelial and Vascular Toxicity Signals Associated With Doxorubicin: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database. [PDF]

Pharmacoepidemiol Drug Saf
Cerbito EF, Kattan L, Dhulkifle H, Korashy HM, Maayah ZH.   +4 more
europepmc   +1 more source

Cross national pharmacovigilance analysis of drug-induced delirium: a comparative study using the US FAERS, Japanese JADER, and canadian CVAR datasets. [PDF]

Front Pharmacol
Jiao J, Liu S, Fang Y, Song X, Zhang X, Wang J.   +5 more
europepmc   +1 more source

Heterogeneity of thromboembolic risk across ALK inhibitors: a retrospective real-world study identifying crizotinib-specific signals and high-risk subpopulations. [PDF]

Front Pharmacol
Hu R, Ai Q, Zhang H, Liu M, Qiu Y, He Y.
europepmc   +1 more source